Closing the Gap Between Innovation and Access in Myasthenia Gravis Care | Euractiv

New therapies are changing what is possible in generalised myasthenia gravis care, yet unequal access across Europe continues to hold patients back. Better diagnosis, specialist referral and more consistent access to care could improve outcomes while supporting health system resilience, workforce participation and economic sustainability.

Raccontata daeuractiv.com